StonvexLoading…
StonvexStonvexStonvexCore line items from CSGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.22B | $1.20B | $1.17B | $1.09B |
Operating Income | $118.75M | $131.33M | $123.88M | $78.75M |
Net Income | $55.88M | $86.85M | $66.25M | $44.06M |
EPS (Diluted) | $1.98 | $3.03 | $2.20 | $1.41 |
Total Assets | $1.54B | $1.50B | $1.44B | $1.35B |
Total Liabilities | $1.26B | $1.22B | $1.17B | $993.30M |
Cash & Equivalents | $180.01M | $161.79M | $186.26M | $150.37M |
Free Cash Flow OCF − CapEx | $141.39M | $113.30M | $103.92M | $26.61M |
Shares Outstanding | 28.37M | 28.85M | 29.54M | 31.27M |